ABCB5-positive stem cells

· RHEACELL GmbH & Co. KG

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ABCB5-positive stem cells, covering 2020-09-10 to 2022-10-07. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa [Phase 1, Phase 2]